NHMRC grant success – women’s health research
By Hudson Institute communications
Federal Minister for Health, The Hon. Greg Hunt MP has announced $18 million in National Health and Medical Research Council (NHMRC) funding for women’s health research.
Hudson Institute scientists have been awarded a total of more than $1 million in Fellowship and Development Grant funding in the announcement.
Congratulations to Dr Tracey Edgell and Dr Vanesa Stojanovska on being awarded funding in support of their life-changing medical research into IVF, pre-eclampsia and preterm brain injury.
Validation of a prognostic assay for embryo transfer outcome
Dr Tracey Edgell
This study will provide strong evidence of the usefulness of a simple blood test to predict the likelihood of a successful IVF embryo transfer. Blood samples from IVF centres in Australia and Singapore will be collected and used to assess the reliability of a previously developed serum signature in predicting the outcome of embryo transfer. This will aid clinical decision-making in the treatment of infertile women, improve IVF success rates and reduce both financial and emotional costs.
Improving breathing of preterm newborns exposed to inflammation during pregnancy
Dr Vanesa Stojanovska
Preterm babies exposed to inflammation during pregnancy have a high incidence of breathing difficulties and brain injury, which often lead to cerebral palsy. Dr Stojanovska’s research aims to investigate whether inflammation injures the fetal brainstem – a life-sustaining brain region which controls our breathing, and whether anti-inflammatory treatments can protect against this injury. Outcomes of this work will guide clinical trials focused on reducing the burden of preterm brain injury.
About Hudson Institute
Hudson Institute’ s research programs deliver in three areas of medical need – inflammation, cancer, women’s and newborn health. More
Hudson News
Get the inside view on discoveries and patient stories
“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”